Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001343

Drug Information
NameAcrivastine    
SynonymsBW A825C; ( E,E )-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid; Acrivastina; -Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (2; CHEMBL1224; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; BIDD:GT0209; C22H24N2O2; Acrivastin; Acrivastine (USAN/INN); BW 825C; E)- (9CI); Acrivastinum; CID5284514; 2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; I14-8671; BW 0270C; BW-825C; (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid; AC1NR4LM; AC1Q5T9P; 2-Propenoic acid, 3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (E,E)-; LS-178016; 87848-99-5; UNII-A20F9XAI7W; (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; AKOS005067182; Acrivastine [USAN:INN:BAN]; Acrivastina [Spanish]; AC-912; D02760; 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-; Acrivastinum [Latin]; Semprex; MolPort-005-942-272; ACRIVASTINE    
Trade NameBenadryl Allergy Relief    
CompanyPfizer Pharmaceuticals    
IndicationAllergic rhinitisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Inflammatory Agents    
CAS NumberCAS 87848-99-5
FormularC22H24N2O2    
PubChem Compound IDCID 5284514.    
PubChem Substance IDSID 193142.    
SuperDrug ATC IDR06AX18;    
SuperDrug CAS ID087848995;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1Comparative tolerability of second generation antihistamines. Drug Saf. 1999 May;20(5):385-401. To Reference
Ref 2Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharmacokinet. 1999 May;36(5):329-52. To Reference
Ref 3Nonsedating histamine H1-receptor antagonists. Clin Pharm. 1989 May;8(5):331-44. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543